EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Plasma and CSF concentrations of N‐terminal tau fragments associate with in vivo neurofibrillary tangle burden

Juan Lantero-Rodriguez, Cécile Tissot, Anniina Snellman, Stijn Servaes, Andrea L Benedet, Nesrine Rahmouni, Laia Montoliu-Gaya, Joseph Therriault, Wagner S Brum, Jenna Stevenson, Firoza Z Lussier, Gleb Bezgin und 8 weitere

Alzheimer's & Dementia · 2023

DOI: 10.1002/alz.13119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2023. Verfasst von Juan Lantero-Rodriguez und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölnd…. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Alzheimer's Association, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Fluid biomarkers capable of specifically tracking tau tangle pathology in vivo are greatly needed. METHODS We measured cerebrospinal fluid (CSF) and plasma concentrations of N‐terminal tau fragments (NTA‐tau), using a novel immunoassay (NTA) in the TRIAD cohort, consisting of 272 individuals assessed with amyloid beta (Aβ) positron emission tomography (PET), tau PET, magnetic resonance imaging (MRI) and cognitive assessments. RESULTS CSF and plasma NTA‐tau concentrations were specifically increased in cognitively impaired Aβ‐positive groups. CSF and plasma NTA‐tau concentrations displayed stronger correlations with tau PET than with Aβ PET and MRI, both in global uptake and at the voxel level. Regression models demonstrated that both CSF and plasma NTA‐tau are preferentially associated with tau pathology. Moreover, plasma NTA‐tau was associated with longitudinal tau PET accumulation across the aging and Alzheimer's disease (AD) spectrum. DISCUSSION NTA‐tau is a biomarker closely associated with in vivo tau deposition in the AD continuum and has potential as a tau tangle biomarker in clinical settings and trials. Highlights An assay for detecting N‐terminal tau fragments (NTA‐tau) in plasma and CSF was evaluated. NTA‐tau is more closely associated with tau PET than amyloid PET or neurodegeneration. NTA‐tau can successfully track in vivo tau deposition across the AD continuum . Plasma NTA‐tau increased over time only in cognitively impaired amyloid‐β positive individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionHumansNeurofibrillary TanglesAmyloid beta-Peptidestau ProteinsPositron-Emission TomographyBiomarkers

Stichwörter der Autor:innen

Alzheimer's diseaseNTAbiomarkerscerebrospinal fluidplasmatau

Substanzen

Amyloid beta-Peptidestau ProteinsBiomarkers

Autor:innen und Institutionen

  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
  • Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, Douglas Mental Health Institute, Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l'Ouest de l'Île de Montré…
  • Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, Canada.
  • Turku PET Centre, University of Turku, Turku University Hospital, Turku, Finland.
  • Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
  • Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Förderung

  • CIHR
  • Alzheimer's Association
  • Canadian Institutes of Health Research
  • Weston Brain Institute
  • Fondation Brain Canada
  • Paulon Säätiö
  • Orionin Tutkimussäätiö
  • Academy of Finland

Zitieren

APA

Lantero-Rodriguez, J., Tissot, C., Snellman, A., Servaes, S., Benedet, A. L., Rahmouni, N., Montoliu-Gaya, L., Therriault, J., Brum, W. S., Stevenson, J., Lussier, F. Z., Bezgin, G., Macedo, A. C., Chamoun, M., Mathotaarachi, S. S., Pascoal, T. A., Ashton, N. J., Zetterberg, H., Neto, P. R., & Blennow, K. (2023). Plasma and CSF concentrations of N‐terminal tau fragments associate with in vivo neurofibrillary tangle burden. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13119

Vancouver

Lantero-Rodriguez J, Tissot C, Snellman A, Servaes S, Benedet AL, Rahmouni N, et al. Plasma and CSF concentrations of N‐terminal tau fragments associate with in vivo neurofibrillary tangle burden. Alzheimer's & Dementia. 2023. doi:10.1002/alz.13119

BibTeX
@article{LanteroRodriguez2023,
  author = {Lantero-Rodriguez, Juan and Tissot, Cécile and Snellman, Anniina and Servaes, Stijn and Benedet, Andrea L and Rahmouni, Nesrine and Montoliu-Gaya, Laia and Therriault, Joseph and Brum, Wagner S and Stevenson, Jenna and Lussier, Firoza Z and Bezgin, Gleb and Macedo, Arthur C and Chamoun, Mira and Mathotaarachi, Sulantha S and Pascoal, Tharick A and Ashton, Nicholas J and Zetterberg, Henrik and Neto, Pedro Rosa and Blennow, Kaj},
  title = {Plasma and CSF concentrations of N‐terminal tau fragments associate with in vivo neurofibrillary tangle burden},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  doi = {10.1002/alz.13119}
}
Kostenlos starten →